⌘K
Loading ticker…
As of 2026-08-24, CytomX Therapeutics, Inc. (CTMX) has a 3-month relative strength percentile of 27 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.7%, relative volume 1.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CTMX is held by 8 ETFs as of May 2026. Top owner: VHT at 0.01% weight, $2M notional. Top 3 carry $3M.
Held by 31 ETFs · $79M across latest filings · largest weight 1.18% (FDM).
Top 8 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| CANC | 0.47% | $824K | new |
| FMED | 0.98% | $403K | — |
| BFOR | 0.18% | $382K | new |
| QQQS | 0.27% | $52K | −0.32 pp |
| IBBQ | 0.05% | $32K | −0.02 pp |
| BIB | 0.03% | $23K | −0.02 pp |
| WSML | 0.00% | $21K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CTMX Jan avg: 20.89% median: 16.14% win: 50% σ: 38.36% n: 4 2022-04-12 → 2026-07-31 | CTMX Feb avg: 3.45% median: -12.98% win: 25% σ: 38.42% n: 4 2022-04-12 → 2026-07-31 | CTMX Mar avg: -14.84% median: -11.75% win: 0% σ: 10.31% n: 4 2022-04-12 → 2026-07-31 | CTMX Apr avg: -8.83% median: -10.21% win: 40% σ: 21.46% n: 5 2022-04-12 → 2026-07-31 | CTMX May avg: 48.94% median: 4.29% win: 60% σ: 116.05% n: 5 2022-04-12 → 2026-07-31 | CTMX Jun avg: -4.83% median: 0.58% win: 60% σ: 16.51% n: 5 2022-04-12 → 2026-07-31 | CTMX Jul avg: -5.69% median: -3.52% win: 40% σ: 14.16% n: 5 2022-04-12 → 2026-07-31 | CTMX Aug avg: -7.56% median: -10.32% win: 25% σ: 8.99% n: 4 2022-04-12 → 2026-07-31 (current) | CTMX Sep avg: 9.76% median: -1.67% win: 25% σ: 31.64% n: 4 2022-04-12 → 2026-07-31 | CTMX Oct avg: -7.02% median: -12.19% win: 25% σ: 12.89% n: 4 2022-04-12 → 2026-07-31 | CTMX Nov avg: 21.38% median: 23.13% win: 100% σ: 11.27% n: 4 2022-04-12 → 2026-07-31 | CTMX Dec avg: 0.04% median: -1.65% win: 25% σ: 8.28% n: 4 2022-04-12 → 2026-07-31 |